Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Inhibrx Inc (INBX)

Inhibrx Inc (INBX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Inhibrx Inc 11025 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037 USA

www.inhibrx.com P: 858-795-4220

Description:

Inhibrx Inc. is a clinical-stage biotechnology company. The company's pipeline is focused on oncology and orphan diseases. Inhibrx Inc. is based in SAN DIEGO.

Key Statistics

Overview:

Market Capitalization, $K 1,801,057
Enterprise Value, $K 1,730,107
Shares Outstanding, K 52,402
Annual Sales, $ 1,800 K
Annual Net Income, $ -241,360 K
Last Quarter Sales, $ 1,630 K
Last Quarter Net Income, $ -93,600 K
EBIT, $ -219,230 K
EBITDA, $ -213,140 K
60-Month Beta 2.87
% of Insider Shareholders 22.20%
% of Institutional Shareholders 82.46%
Float, K 40,769
% Float 77.80%
Short Volume Ratio 0.03

Growth:

1-Year Return 36.66%
3-Year Return 104.95%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -1.73 on 02/28/24
Latest Earnings Date 05/13/24
Earnings Per Share ttm -5.03
EPS Growth vs. Prev Qtr -57.27%
EPS Growth vs. Prev Year -82.11%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

INBX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -678.51%
Return-on-Assets % -91.73%
Profit Margin % -13,408.89%
Debt/Equity 4.76
Price/Sales 993.89
Price/Cash Flow N/A
Price/Book 153.88
Book Value/Share 0.92
Interest Coverage -6.53
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar